Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Mediwelcome Healthcare Management & Technology Inc. ( (HK:2159) ) just unveiled an update.
Mediwelcome Healthcare Management & Technology Inc. announced its unaudited consolidated interim results for the six months ending June 30, 2025. The company reported a decrease in revenue from RMB 140,670,000 in 2024 to RMB 127,052,000 in 2025, with a reduced net loss of RMB 4,086,000 compared to RMB 22,929,000 in the previous year. This improvement in financial performance is attributed to lower administrative and research expenses, despite a decline in revenue, indicating a strategic focus on cost management.
The most recent analyst rating on (HK:2159) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Mediwelcome Healthcare Management & Technology Inc. stock, see the HK:2159 Stock Forecast page.
More about Mediwelcome Healthcare Management & Technology Inc.
Mediwelcome Healthcare Management & Technology Inc. operates in the healthcare management and technology industry, focusing on providing healthcare management services and technological solutions.
Average Trading Volume: 1,331,213
Technical Sentiment Signal: Buy
Current Market Cap: HK$518M
For a thorough assessment of 2159 stock, go to TipRanks’ Stock Analysis page.